Aligos Therapeutics (ALGS) Total Non-Current Liabilities (2019 - 2025)
Aligos Therapeutics (ALGS) reported Total Non-Current Liabilities of $47,000 for Q4 2025, up 2.2% from $46,000 a year earlier and up 2.2% from the prior quarter.
Aligos Therapeutics (ALGS) Total Non-Current Liabilities (2019 - 2025) Analysis & Trends
Dating back to Q4 2019, Aligos Therapeutics' Total Non-Current Liabilities record includes 21 quarters.
- Total Non-Current Liabilities has a five-year compound annual growth rate of -34.1% (FY2020 to FY2025).
- By year, Total Non-Current Liabilities came in at $46,000 in FY2024 (unchanged), $46,000 in FY2023, -$2.01 billion in FY2022 and $133,000 in FY2021 (-64.9%).
- The Q4 2025 figure ranks as the highest quarterly Total Non-Current Liabilities since Q3 2022.
- Year over year, Total Non-Current Liabilities gained in 1 of the last six quarters, with growth averaging 0.4%.
- The high point for year-over-year Total Non-Current Liabilities in five years was Q1 2022 (growth of 47.1%); the low point was Q3 2023 (a decline of 99.9%).
- Per Business Quant data, the three quarters before Q4 2025 came in at $46,000 (Q3 2025), $46,000 (Q2 2025) and $46,000 (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 60.81 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 102.65 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 117.60 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 79.95 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | -36.84 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 76.12 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 36.05 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 96.04 Bn |
| 10 | Aligos Therapeutics | 21.97 Mn | -314.86 Mn | - | - |
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 47,000.00 |
| Sep 30, 2025 | 46,000.00 |
| Jun 30, 2025 | 46,000.00 |
| Mar 31, 2025 | 46,000.00 |
| Dec 31, 2024 | 46,000.00 |
| Sep 30, 2024 | 46,000.00 |
| Jun 30, 2024 | 46,000.00 |
| Mar 31, 2024 | 46,000.00 |
| Dec 31, 2023 | 46,000.00 |
| Sep 30, 2023 | 46,000.00 |
| Dec 31, 2022 | -2.01 Bn |
| Sep 30, 2022 | 41.92 Mn |
| Jun 30, 2022 | 45.41 Mn |
| Mar 31, 2022 | 57.45 Mn |
| Dec 31, 2021 | 133,000.00 |
| Sep 30, 2021 | 45.79 Mn |
| Jun 30, 2021 | 42.73 Mn |
| Mar 31, 2021 | 39.05 Mn |
| Dec 31, 2020 | 379,000.00 |
| Sep 30, 2020 | 227.94 Mn |
Aligos Therapeutics Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=ALGS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "ALGS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=ALGS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();